US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

157.87

-0.6700-0.42%

Post-market: 157.83-0.0400-0.03%17:29 EST

Volume:12.89M

Turnover:2.04B

Market Cap:41.79B

PE:-11.10

High:158.50

Open:158.01

Low:157.31

Close:158.54

52wk High:160.59

52wk Low:127.35

Shares:264.72M

Float Shares:264.72M

Volume Ratio:0.94

T/O Rate:4.87%

Dividend:2.48

Dividend Rate:1.57%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.21

PE(LYR):-11.10

Loading ...

Overview Company News Filings

Molina Healthcare Inc. Stock Underperforms Tuesday When Compared To Competitors

Covista Unveils Purpose at Scale Healthcare Growth Strategy

Analysts Conflicted on These Healthcare Names: Elanco Animal Health (ELAN) and Henry Schein (HSIC)

Tsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare Vision

Tsumura to Take Yomeishu Private in ¥6.8 Billion Multi-Stage Deal to Expand Healthcare Portfolio

VR-CARES Study Shows How Virtual Reality Could Reshape Caregiver Support and Healthcare Ecosystems

Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments

Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Amid AI Disruption Fears

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)

Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

Septerna to Present at TD Cowen 46th Annual Health Care Conference

Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference

Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds

Is It Time To Reassess Tenet Healthcare (THC) After Its 3 Year Share Price Surge?

Simply Wall St.

Morgan Stanley Remains a Buy on ConvaTec (CTEC)

Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target

Quadria-Led Consortium Completes $470 Million Take-Private of Apex Healthcare

Hextar Healthcare Malaysia 4th-Quarter 2025 Earnings Summary Table

EPF Increases Substantial Stake in IHH Healthcare to 12.85%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":157.87,"timestamp":1771966800000,"preClose":158.54,"halted":0,"volume":12887140,"hourTrading":{"tag":"盘后","latestPrice":157.83,"preClose":157.87,"latestTime":"17:29 EST","volume":272957,"amount":43086153.2672,"timestamp":1771972141061,"change":-0.04,"changeRate":-0.000253,"amplitude":0.002724},"delay":0,"changeRate":-0.004226062823262189,"floatShares":264715324,"shares":264715324,"eps":-14.217021,"marketStatus":"Post-Mkt","change":-0.67,"latestTime":"02-24 17:43:35 EST","open":158.01,"high":158.5,"low":157.3075,"amount":2036364004.5279999,"amplitude":0.007522,"askPrice":158.2,"askSize":3,"bidPrice":157.62,"bidSize":1,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":158.54,"sharesOutstanding":264715324,"nav":156.768162,"aum":41498934785.52,"dividendRate":0.015695,"bidAskSpread":0.000078,"preHourTrading":{"tag":"盘前","latestPrice":158.25,"preClose":158.54,"latestTime":"09:28 EST","volume":2236,"amount":354434.88912,"timestamp":1771943328458,"change":-0.29,"changeRate":-0.001829,"amplitude":0.005385},"postHourTrading":{"tag":"盘后","latestPrice":157.83,"preClose":157.87,"latestTime":"17:29 EST","volume":272957,"amount":43086153.2672,"timestamp":1771972141061,"change":-0.04,"changeRate":-0.000253,"amplitude":0.002724},"volumeRatio":0.941813,"impliedVol":0.1443,"impliedVolPercentile":0.1673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":264715324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.941813,"shares":264715324,"dividePrice":2.4778,"high":158.5,"amplitude":0.007522,"preClose":158.54,"low":157.3075,"week52Low":127.35,"pbRate":"1.21","psRate":"63.44","week52High":160.59,"institutionHeld":0.7846,"latestPrice":157.87,"committee":-0.5,"eps":-14.217021,"divideRate":0.015695,"volume":12887140,"delay":0,"ttmEps":-14.217021,"open":158.01,"prevYearClose":154.8,"prevWeekClose":156.82,"prevMonthClose":154.74,"prevQuarterClose":154.8,"fiveDayClose":157.37,"twentyDayClose":158.1,"sixtyDayClose":158.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XLV","amount":0.564539,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XLV","amount":0.621655,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.236696,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.285214,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614726491","title":"Molina Healthcare Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2614726491","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614726491?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:21","pubTimestamp":1771971660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Molina Healthcare Inc.  shed 5.06% to $148.31 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.77% to 6,890.07 and the Dow Jones Industrial Average  rising 0.76% to 49,174.50.The stock's fall snapped a seven-day winning streak.Molina Healthcare Inc. closed 58.80% short of its 52-week high of $359.97, which the company reached on April 4th.The stock underperformed when compared to some of its competitors Tuesday, as Humana Inc.  fell 3.60% to $174.64 and Centene Corp.  fell 2.24% to $42.37.Trading volume  eclipsed its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","MOH"],"gpt_icon":0},{"id":"2614726463","title":"Covista Unveils Purpose at Scale Healthcare Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2614726463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614726463?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:12","pubTimestamp":1771971157,"startTime":"0","endTime":"0","summary":"The latest update is out from Adtalem Global Education ( ($ATGE) ). On February 24, 2026, Covista used its Investor Day to unveil “Purpose at Scale...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/covista-unveils-purpose-at-scale-healthcare-growth-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/covista-unveils-purpose-at-scale-healthcare-growth-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","HCSG","BK4137","XLV","LABU","XBI","LU0029874061.USD","BK4585","BK4588","BK4581"],"gpt_icon":0},{"id":"2614596747","title":"Analysts Conflicted on These Healthcare Names: Elanco Animal Health (ELAN) and Henry Schein (HSIC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614596747","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614596747?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:00","pubTimestamp":1771963228,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elanco Animal Health (ELAN – Research Report) and Henry Schein (H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-elanco-animal-health-elan-and-henry-schein-hsic-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-elanco-animal-health-elan-and-henry-schein-hsic-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4175","LU0029874061.USD","HSIC","BK4588","BK4585","BK4581","LABU","LU1941712264.USD","XBI","ELAN","BK4137","HCSG","BK4007","BK4561","LU1941712348.USD","XLV"],"gpt_icon":0},{"id":"2614744694","title":"Tsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare Vision","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744694","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614744694?lang=en_us&edition=fundamental","pubTime":"2026-02-25 02:23","pubTimestamp":1771957423,"startTime":"0","endTime":"0","summary":"The latest update is out from Tsumura & Co ( ($JP:4540) ). Tsumura & Co. has concluded a contract to acquire shares of Yomeishu Seizo Co., Ltd., al...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tsumura-aligns-yomeishu-share-acquisition-with-long-term-kampo-healthcare-vision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tsumura-aligns-yomeishu-share-acquisition-with-long-term-kampo-healthcare-vision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","LABU","LU0128526141.USD","XLV","BK4581","LU0029874061.USD","XBI","HCSG","BK4588"],"gpt_icon":0},{"id":"2614744541","title":"Tsumura to Take Yomeishu Private in ¥6.8 Billion Multi-Stage Deal to Expand Healthcare Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744541","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614744541?lang=en_us&edition=fundamental","pubTime":"2026-02-25 02:23","pubTimestamp":1771957395,"startTime":"0","endTime":"0","summary":"Tsumura & Co ( ($JP:4540) ) has shared an announcement. Tsumura & Co. has agreed a four-party master deal with Yomeishu Seizo, Reno and Yuzawa unde...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tsumura-to-take-yomeishu-private-in-¥6-8-billion-multi-stage-deal-to-expand-healthcare-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tsumura-to-take-yomeishu-private-in-¥6-8-billion-multi-stage-deal-to-expand-healthcare-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4585","XBI","BK4581","LABU","BK4137","SSI","HCSG","LU0128526141.USD","XLV","BK4588"],"gpt_icon":0},{"id":"2614465367","title":"VR-CARES Study Shows How Virtual Reality Could Reshape Caregiver Support and Healthcare Ecosystems","url":"https://stock-news.laohu8.com/highlight/detail?id=2614465367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614465367?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:31","pubTimestamp":1771950716,"startTime":"0","endTime":"0","summary":"Trane Technologies Plc ($TT) announced an update on their ongoing clinical study. The VR-CARES study, officially titled “VR-CARES: Feasibility of V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vr-cares-study-shows-how-virtual-reality-could-reshape-caregiver-support-and-healthcare-ecosystems?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vr-cares-study-shows-how-virtual-reality-could-reshape-caregiver-support-and-healthcare-ecosystems?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","VR","BK4588","BK4585","BK4581","LABU","HCSG","BK4137","XBI","XLV"],"gpt_icon":0},{"id":"2613101547","title":"Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2613101547","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613101547?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:15","pubTimestamp":1771942500,"startTime":"0","endTime":"0","summary":"Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243707/0/en/Professional-Golfer-Max-Homa-Joins-Arcutis-Free-to-Be-Me-Campaign-Urging-Individuals-with-Seborrheic-Dermatitis-to-Tee-Up-a-Conversation-with-Their-Healthcare-Provider-About-Long-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4137","LU0029874061.USD","BK4581","LU0128526141.USD","XBI","XLV","HCSG","LABU","BK4588"],"gpt_icon":0},{"id":"2613465712","title":"Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Amid AI Disruption Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2613465712","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613465712?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:52","pubTimestamp":1771941171,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.02% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Tuesday's premarket activity amid concerns around t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XSD","OWL","IGV","AMD.AU","TNC.AU","XLF","VHT","RTH.AU","IYH","IYW","BETH","RTH","UNG","SPY","VDC","IGM","EQR","IYJ","EEM","XLY","VHT.AU","VIS","IVV","XLE","XRT","SOXX","XLI",".DJI","AMD","HD","SPY.AU","FAS","FMS.AU","XLV","CEG","TNC","EETH","IYK","XLK","BITO","IYE","FMS","IBB","XLP","FAZ"],"gpt_icon":1},{"id":"2613717809","title":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613717809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613717809?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:50","pubTimestamp":1771941010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD – Research Report), Janux Ther...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-janux-therapeutics-inc-janx-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-janux-therapeutics-inc-janx-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0234570918.USD","GILD","LU2468319806.SGD","LU2324357040.USD","LU0128526141.USD","LU0070302665.USD","LU0109394709.USD","LU1674673428.USD","LU1571399168.USD","LU0162691827.USD","LU0122379950.USD","HCSG","LU0432979614.USD","LU0823416689.USD","BK4585","IE00B19Z3B42.SGD","JANX","BK4137","LU0208291251.USD","LU0965508806.USD","LU1699723380.USD","BK4196","LU0965509010.AUD","LU1023059063.AUD","LU1061106388.HKD","IE00B3T34201.USD","LU0114720955.EUR","LABU","BK4578","IE00BSNM7G36.USD","BK4539","LU0320765992.SGD","LU1839511570.USD","SG9999015986.USD","BK4532","CVS","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4504","LU0965509101.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0061475181.USD","LU1430594728.SGD","LU0889565916.HKD","LU0211331839.USD","BK4550","LU1983299246.USD"],"gpt_icon":0},{"id":"2613714472","title":"Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714472?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Feb.  24, 2026  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243524/0/en/Acrivon-Therapeutics-to-Present-at-the-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4127","BK4588","BK4139","TD","BK4539","BK4207","COWN","LENZ","XBI","BK4581","XLV","BK4007","BK4566"],"gpt_icon":0},{"id":"2613714407","title":"Septerna to Present at TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714407","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714407?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb.  24, 2026   -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 3:10 p.m. ET in Boston. A live webcast of the presentation will be available in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation. About SepternaSepterna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243503/0/en/Septerna-to-Present-at-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","SEPN","TD","BK4585","BK4007","LABU","BK4588","XLV","BK4207","XBI","BK4127","BK4566","BK4599","COWN","GPCR"],"gpt_icon":0},{"id":"2613719397","title":"Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719397","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719397?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"NEW YORK and WALTHAM, Mass., Feb.  24, 2026  (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243371/0/en/Dianthus-Therapeutics-to-Participate-in-The-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4207","BK4581","TD","BK4566","LABU","LENZ","XBI","BK4539","BK4588","COWN","BK4585","XLV","BK4007","BK4127"],"gpt_icon":0},{"id":"2613560719","title":"Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613560719","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613560719?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and SUZHOU, China, Feb.  24, 2026  (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (\"Transcenta Therapeutics\"), a global clinical stage biopharmaceutical company with full","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243379/0/en/Transcenta-Therapeutics-to-Present-at-the-36th-Annual-Oppenheimer-Healthcare-Life-Sciences-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0128526141.USD","BK4539","LU0029874061.USD","XBI","BK4137","BK4585","BK4007","BK4588","OPY","LENZ","LABU","BK4139","XLV","HCSG","BK4127"],"gpt_icon":0},{"id":"2613971569","title":"Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2613971569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613971569?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:55","pubTimestamp":1771934146,"startTime":"0","endTime":"0","summary":"Fresenius Medical Care AG & Co. KGaA, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Anna Ractliffe from Bank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-rating-on-fresenius-medical-care-amid-unsustainable-earnings-quality-and-structural-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-rating-on-fresenius-medical-care-amid-unsustainable-earnings-quality-and-structural-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","XBI","BK4581","XLV"],"gpt_icon":0},{"id":"2613716527","title":"Is It Time To Reassess Tenet Healthcare (THC) After Its 3 Year Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716527","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716527?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:23","pubTimestamp":1771932217,"startTime":"0","endTime":"0","summary":"If you are wondering whether Tenet Healthcare's current share price lines up with its underlying value, this article is designed to walk you through that question step by step.\nTenet Healthcare's stock last closed at US$233.77, with returns of 1.2% over 7 days, 23.8% over 30 days, 17.2% year to date, 77.7% over 1 year and 299.3% over 3 years. These figures can change how investors think about both upside and risk.\nRecent news around Tenet Healthcare has focused on its role in the US hospital...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-it-time-to-reassess-tenet-healthcare-thc-after-its-3-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-it-time-to-reassess-tenet-healthcare-thc-after-its-3-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0963586101.USD","LU1201861165.SGD","BK4588","THC.AU","BK4585","BK4581","LU0130103400.USD","BK4185","LABU","LU0648000940.SGD","LU2324357040.USD","XBI","DCF","THC","XLV"],"gpt_icon":0},{"id":"2613189067","title":"Morgan Stanley Remains a Buy on ConvaTec (CTEC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613189067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613189067?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:18","pubTimestamp":1771931883,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Aisyah Noor maintained a Buy rating on ConvaTec today and set a price target of p270.00. Noor covers the Healthcare sector, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-convatec-ctec-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-convatec-ctec-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1363072403.SGD","LU1791710582.SGD","LU0106831901.USD","LU2271345857.HKD","LU0882574139.USD","LU0098860793.USD","LU1720051108.HKD","BK4588","LU0795875169.SGD","BK4534","LU2111349929.HKD","LU1244550221.USD","LU1732799900.SGD","LU1732800096.USD","LU1720051017.SGD","LU1244550494.USD","LU1989772840.SGD","LU0158827781.USD","LU1791710400.SGD","BK4581","LU1162221912.USD","LU0234570918.USD","LU2347655156.SGD","LU1668664300.SGD","LU0225283273.USD","IE00BKVL7J92.USD","LU0106261372.USD","CTEC","LU0158827948.USD","LU1244550577.SGD","XBI","LU2357305700.SGD","BK4127","LU0912757837.SGD","BK4516","LU1989772923.USD","LU1548497426.USD","LU2023251221.USD","LU1074936037.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","XLV","LU2133065610.SGD","LU2089284900.SGD","LU0320765646.SGD","BK4585","LU2089283258.USD","LU0528227936.USD","BK4504","LABU"],"gpt_icon":0},{"id":"2613910718","title":"Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2613910718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613910718?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:16","pubTimestamp":1771931776,"startTime":"0","endTime":"0","summary":"Legend Biotech, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mitchell Kapoor from H.C. Wainwright reiterate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-bcma-car-t-leader-with-lower-commercial-risk-and-dcf-supported-upside-to-50-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-bcma-car-t-leader-with-lower-commercial-risk-and-dcf-supported-upside-to-50-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LABU","DCF","XBI","BK4581","LEGN","BK4139","BK4585","BK4588","BK4230","CAR","BK4022","XLV"],"gpt_icon":0},{"id":"2613945087","title":"Quadria-Led Consortium Completes $470 Million Take-Private of Apex Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2613945087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613945087?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:55","pubTimestamp":1771926900,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--A consortium led by Asian private-equity firm Quadria Capital has taken a major Malaysian pharmaceutical company private in the latest sign of deal momentum in the region.Quadria, which manages $4.2 billion in assets, said it completed the take-private acquisition of Apex Healthcare on Tuesday.The deal values Apex, which makes pharmaceuticals, consumer healthcare products and medical devices, at about $470 million.Quadria said the transaction is the largest of its kind in the Southeast Asia healthcare space in the past five years and biggest ever in Malaysia.Investor caution amid uncertainty over global trade policy has weighed on private-equity investments over the past year, but Asia-Pacific is still viewed as a region of long-term opportunity thanks to a diverse mix of mature markets and fast-growing emerging economies, said Andrew Thompson at KPMG.While overall deal values remain subdued, there are signs that volumes are stabilizing and valuations resetting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4137","BK4581","XLV","LU0128526141.USD","BK4585","HCSG","LABU","LU0029874061.USD"],"gpt_icon":0},{"id":"2613279451","title":"Hextar Healthcare Malaysia 4th-Quarter 2025 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2613279451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613279451?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:52","pubTimestamp":1771926720,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      35,536,000         41,654,000. PreTax Profit               -21,211,000        -10,634,000. Net Profit                  -31,386,000         -7,990,000. Earnings Per Share            -2.85 Sen          -0.76 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                     148,114,000        146,950,000. PreTax Profit               -37,480,000        -18,981,000. Net Profit                  -44,956,000        -13,920,000. Earnings Per Share            -4.08 Sen          -1.33 Sen. Dividend                       0.00 Sen           0.00 Sen. Copyright (c) 2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","XLV"],"gpt_icon":0},{"id":"2613794404","title":"EPF Increases Substantial Stake in IHH Healthcare to 12.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613794404","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613794404?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:44","pubTimestamp":1771926264,"startTime":"0","endTime":"0","summary":"The latest update is out from IHH Healthcare Bhd ( ($IHHHF) ). Employees Provident Fund Board, a substantial shareholder in IHH Healthcare Berhad, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-increases-substantial-stake-in-ihh-healthcare-to-12-85?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-increases-substantial-stake-in-ihh-healthcare-to-12-85?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","HCSG","LU0128526141.USD","BK4581","XBI","BK4137","XLV","LABU","LU0029874061.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":1,"totalSize":324,"code":"91000000","status":"200"}]}}